HK1037535A1 - Sleep inducing agent. - Google Patents

Sleep inducing agent.

Info

Publication number
HK1037535A1
HK1037535A1 HK01108459A HK01108459A HK1037535A1 HK 1037535 A1 HK1037535 A1 HK 1037535A1 HK 01108459 A HK01108459 A HK 01108459A HK 01108459 A HK01108459 A HK 01108459A HK 1037535 A1 HK1037535 A1 HK 1037535A1
Authority
HK
Hong Kong
Prior art keywords
group
cycloalkyl
vinylene
alkyl
inducing agent
Prior art date
Application number
HK01108459A
Other languages
English (en)
Inventor
Fumie Sato
Tohru Tanami
Kazuya Kameo
Kenji Yamada
Shigeru Okuyama
Naoya Ono
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of HK1037535A1 publication Critical patent/HK1037535A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK01108459A 1998-05-25 2001-11-30 Sleep inducing agent. HK1037535A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14262298 1998-05-25
PCT/JP1999/002723 WO1999061029A1 (fr) 1998-05-25 1999-05-25 Agent somnifere

Publications (1)

Publication Number Publication Date
HK1037535A1 true HK1037535A1 (en) 2002-11-08

Family

ID=15319631

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01108459A HK1037535A1 (en) 1998-05-25 2001-11-30 Sleep inducing agent.
HK01108464A HK1037610A1 (en) 1998-05-25 2001-11-30 Prostaglandin derivative.

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK01108464A HK1037610A1 (en) 1998-05-25 2001-11-30 Prostaglandin derivative.

Country Status (14)

Country Link
US (2) US6395786B1 (fr)
EP (2) EP1083168B1 (fr)
JP (3) JP4354644B2 (fr)
KR (2) KR100623941B1 (fr)
CN (2) CN1144588C (fr)
AT (2) ATE316378T1 (fr)
AU (2) AU742118B2 (fr)
CA (2) CA2333038C (fr)
DE (2) DE69912277T2 (fr)
DK (1) DK1083168T3 (fr)
ES (2) ES2211083T3 (fr)
HK (2) HK1037535A1 (fr)
PT (1) PT1083168E (fr)
WO (2) WO1999061029A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0200258A2 (hu) 1999-03-05 2002-05-29 The Procter & Gamble Co. C16-telítetlen FP-szelektív prosztaglandin analógok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
KR20020040871A (ko) 1999-11-24 2002-05-30 우에하라 아끼라 경비 투여 제제
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
NZ531503A (en) 2001-08-31 2006-01-27 Sucampo Ag Prostaglandin analogs as chloride channel opener
US7163952B2 (en) * 2001-12-03 2007-01-16 Japan Tobacco Inc. Azole compound and medicinal use thereof
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
US7763652B2 (en) 2002-07-12 2010-07-27 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
AU2003254850B2 (en) * 2002-08-09 2008-05-15 Fumie Sato Antipruritic agent
US7737182B2 (en) 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
US7037522B2 (en) * 2002-09-27 2006-05-02 Western Holdings, L.L.C. Nocturnal muscle enhancing composition and method
JP4477504B2 (ja) * 2002-11-13 2010-06-09 大正製薬株式会社 鎮痒剤
EP1598335A4 (fr) * 2003-02-20 2006-04-12 Taisho Pharmaceutical Co Ltd Derives de prostaglandine
KR20050119201A (ko) * 2003-04-09 2005-12-20 니뽄 다바코 산교 가부시키가이샤 ５원 헤테로방향족 고리 화합물 및 이의 의약적 용도
JP5382898B2 (ja) * 2004-02-06 2014-01-08 大正製薬株式会社 乾皮症治療剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322749C (fr) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandines de la serie d, et tranquilisants et soporifiques en contenant
JPH07103096B2 (ja) 1987-01-28 1995-11-08 株式会社上野製薬応用研究所 プロスタグランジンｄ類およびそれを含む鎮静・睡眠剤
DE4036140A1 (de) * 1990-11-09 1992-05-14 Schering Ag 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JPH05117230A (ja) 1991-04-22 1993-05-14 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
EP0591532A4 (fr) 1991-04-22 1994-11-09 Taisho Pharmaceutical Co Ltd Analogue de prostaglandine e 1?.
AU664915B2 (en) 1992-07-24 1995-12-07 Fumie Sato Prostaglandin derivative
JP3408835B2 (ja) 1993-03-23 2003-05-19 大正製薬株式会社 Ｅ型プロスタグランジン類の製造方法
JP3579448B2 (ja) * 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3506485B2 (ja) 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
US5599838A (en) * 1996-02-23 1997-02-04 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives

Also Published As

Publication number Publication date
KR100570521B1 (ko) 2006-04-12
CA2334355A1 (fr) 1999-12-02
WO1999061029A1 (fr) 1999-12-02
DE69929594T2 (de) 2006-12-07
JP4354644B2 (ja) 2009-10-28
JP2000044477A (ja) 2000-02-15
KR20010043595A (ko) 2001-05-25
CA2333038A1 (fr) 1999-12-02
DE69929594D1 (de) 2006-04-13
AU3851299A (en) 1999-12-13
CN1303292A (zh) 2001-07-11
CN1303370A (zh) 2001-07-11
DE69912277D1 (de) 2003-11-27
CN1144783C (zh) 2004-04-07
WO1999061419A1 (fr) 1999-12-02
US6329539B1 (en) 2001-12-11
DK1083168T3 (da) 2003-12-15
ATE316378T1 (de) 2006-02-15
EP1083168A1 (fr) 2001-03-14
AU3851499A (en) 1999-12-13
EP1083168A4 (fr) 2002-09-04
AU742232B2 (en) 2001-12-20
ES2211083T3 (es) 2004-07-01
EP1082961A4 (fr) 2001-07-11
KR20010043596A (ko) 2001-05-25
CN1144588C (zh) 2004-04-07
CA2333038C (fr) 2008-12-02
ATE252555T1 (de) 2003-11-15
EP1082961B1 (fr) 2006-01-25
EP1082961A1 (fr) 2001-03-14
US6395786B1 (en) 2002-05-28
HK1037610A1 (en) 2002-11-08
DE69912277T2 (de) 2004-07-15
AU742118B2 (en) 2001-12-20
PT1083168E (pt) 2004-03-31
KR100623941B1 (ko) 2006-09-13
EP1083168B1 (fr) 2003-10-22
ES2257860T3 (es) 2006-08-01
JP4409767B2 (ja) 2010-02-03
CA2334355C (fr) 2009-01-27

Similar Documents

Publication Publication Date Title
HK1037535A1 (en) Sleep inducing agent.
LU91943I2 (fr) Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®)
EP0997462A4 (fr) Nouveaux derives de naphthyridine ou leurs sels
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
IE883859L (en) Novel antiarrhythmic agents i
ES2046641T3 (es) Composicion antitumoral.
HK1048466A1 (en) Prostaglandin derivatives
ES2019554A6 (es) Procedimiento para preparar n,n -ditrimetoxibenzoilpiperazinas sustituidas en posicion 2"
NO20006350L (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
EP0785190A3 (fr)
HK1034074A1 (en) 1,2-dihydro-2-oxoquinoline derivatives
HK1078072A1 (en) Prostaglandin derivatives
EP0308319A3 (en) 4-piperidinecarboxamide derivatives
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
EP0717990A4 (fr) Composition servant de remede a la pharmacodependance

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120525